Prelude Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Prelude Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,000	Closed	-$1.05M	–	2342
2021 Q3	$1.05M	Hold	12,000	–	–	0.03%	550
2021 Q2	$1.07M	Hold	12,000	–	–	0.03%	573
2021 Q1	$910K	Hold	12,000	–	–	0.02%	637
2020 Q4	$818K	Hold	12,000	–	–	0.02%	545
2020 Q3	$638K	Buy	+12,000	New	+$715K	0.03%	377

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's SYNH Position: Q3 2023 in Review

Prelude Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 132,619 shares — an estimated $5.59M sold.

Prelude Capital Management first reported a position in SYNH in Q1 2015 and held it in 18 quarters. The position peaked at $5.59M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Prelude Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Prelude Capital Management sold 132,619 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5.59M.
Prelude Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 18 quarters.
Prelude Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.59M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.